Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat
The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Atomoxetine is a noradrenaline-specific reuptake inhibitor used clinically for the treatment of childhood and adult attention deficit hyperactivity disorder (ADHD). Studies in human volunteers and patient groups have shown that atomoxetine improves stop-signal reaction time (SSRT) performance, an effect consistent with a reduction in motor impulsivity. However, ADHD is a heterogeneous disorder and it is of interest to determine whether atomoxetine is similarly effective against other forms of impulsivity, as well as the attentional impairment present in certain subtypes of ADHD. The present study examined the effects of atomoxetine on impulsivity using an analogous SSRT task in rats and two additional tests of impulsivity; delay discounting of reward and the five-choice serial reaction time task (5CSRTT), the latter providing an added assessment of sustained visual attention. Atomoxetine produced a significant dose-dependent speeding of SSRT. In addition, atomoxetine produced a selective, dose-dependent decrease in premature responding on the 5CSRTT. Finally, on the delay-discounting task, atomoxetine significantly decreased impulsivity by increasing preference for the large-value reward across increasing delay. These findings conclusively demonstrate that atomoxetine decreases several distinct forms of impulsivity in rats. The apparent contrast of these effects with stimulant drugs such as amphetamine and methylphenidate, which generally act to increase impulsivity on the 5CSRTT, may provide new insights into the mechanisms of action of stimulant and nonstimulant drugs in ADHD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Atomoxetine improves measures of PFC cognitive function in rats (Newman et al., 2008; Robinson et al., 2008; Seu et al., 2009), monkeys (Gamo et al., 2010; Seu et al., 2009), and humans (Chamberlain et al., 2007; Chamberlain et al., 2006).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Robinson et al., 2008
In the citing paper
“For example, atomoxetine, a relatively selective norepinephrine uptake inhibitor, improves response inhibition in both the 5-CRSTT and the stop-signal task (Robinson et al 2008).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Robinson et al 2008
Citations
Cites
On the ability to inhibit thought and action: a theory of an act of control
Logan, G. D., & Cowan, W. B. (1984) · Psychological Review · doi:10.1037/0033-295x.91.3.295 · Cited by 2,590 · cited 1×
“Recently, atomoxetine has been shown to improve performance in normal human volunteers in a stop-signal reaction time (SSRT) task (Chamberlain et al, 2006), which provides a measure of motor inhibition and the propensity toward behavioral impulsivity (Logan and Cowan, 1984).”
BackgroundInhibitory Processes in Attention, Memory and Language
Carr, T. H., & Dagenbach, D. (1994) · Medical Entomology and Zoology · Cited by 2,364
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771 · cited 2×
“…rights reserved 0893-133X/08 $30.00 www.neuropsychopharmacology.org improved, in both humans and rodents, by stimulants such as methylphenidate (Tannock et al, 1989; Aron et al, 2003b; Eagle et al, 2007b) and by the anti-narcoleptic agent modafinil (Turner et al, 2003, 2004; Eagle et al, 2007b).”
BackgroundInfluentialSelf-citationPrefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329 · cited 2×
“Subjects were trained to detect the location of a brief visual stimulus (0.5 s in duration) presented pseudorandomly in one of five apertures over a large number of trials, as described previously (Dalley et al, 2004).”
MethodInfluentialSelf-citationThe 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282 · cited 3×
“The 5CSRTT also allows for the measurement of attentional capacity because of its requirement for rats to detect brief visual targets (Robbins, 2002).”
BackgroundMethodSelf-citationBymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123 · cited 7×
“Neuropsychopharmacology striatal DA (Bymaster et al, 2002).”
BackgroundInfluentialOn the ability to inhibit thought and action: A users' guide to the stop signal paradigm
Logan, G. D. (1994) · UvA-DARE (University of Amsterdam) · Cited by 1,115
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948 · cited 1×
“…with stimulant and nonstimulant medications have shown that atomoxetine, amphetamine, and methylphenidate all enhance DA and NA in the PFC (for review see Solanto, 1998; Arnsten and Li, 2005; Arnsten, 2006a, b) but atomoxetine does not increase DA in the nucleus accumbens (Bymaster et al, 2002).”
BackgroundImpulsive choice induced in rats by lesions of the nucleus accumbens core
Cardinal, R. N., Pennicott, D. R., Lakmali, C., Sugathapala, Robbins, T. W., & Everitt, B. J. (2001) · Science · doi:10.1126/science.1060818 · Cited by 923 · cited 1×
“For example, lesions of the nucleus accumbens core region impair delay discounting by enhancing impulsive choice (Cardinal et al, 2001) but have no effect on SSRT (Eagle and Robbins, 2003b).”
BackgroundSelf-citationRubia, K., Smith, A. B., Brammer, M. J., & Taylor, E. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00275-1 · Cited by 852 · cited 1×
“SSRT itself is especially susceptible to damage to the right inferior frontal cortex in humans (Aron et al, 2003a; Rubia et al, 2003), and in rats following damage to the ventral orbitofrontal cortex, but not the prelimbic or infralimbic prefrontal cortex (PFC) (Eagle and Robbins, 2003b; Eagle et…”
Background
Cited by
Items 101–200 of 369
A review of the 5-Choice Serial Reaction Time (5-CSRT) task in different vertebrate models
Fizet, J., Cassel, J., Kelche, C. R., & Meunier, H. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.027 · Cited by 74
Jupp, B., Caprioli, D., & Dalley, J. W. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.010934 · Cited by 65
Self-citationvan Enkhuizen, J., Geyer, M. A., & Young, J. W. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2854-2 · Cited by 64
“Given that selective NET inhibition reduces premature responding (Navarra et al. 2008; Paine et al. 2007; Robinson et al. 2008), while selective DAT inhibition increases premature responding (Loos et al. 2010), combined NET and DAT inhibition may obfuscate the effect of DAT inhibition alone,…”
Economidou, D., Dalley, J. W., & Everitt, B. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.040 · Cited by 70
Self-citationAtomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson’s Disease
Borchert, R. J., Rittman, T., Passamonti, L., Ye, Z., Sami, S. A. K., Jones, P. S., Nombela, C., Rodríguez, P. V., Vatansever, D., Rae, C. L., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.18 · Cited by 65
“In preclinical studies atomoxetine improves attentional set-shifting (Newman et al, 2008) and response inhibition (Robinson et al, 2008).”
Self-citationCognitive remediation in the treatment of stimulant abuse disorders: A research agenda.
Vocci, F. J. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0014101 · Cited by 68
The influence of sex-linked genetic mechanisms on attention and impulsivity
Trent, S., & Davies, W. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.09.011 · Cited by 70
Parker, M. O., Millington, M. E., Combe, F. J., & Brennan, C. H. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.037 · Cited by 64
Binge-eating disorder: Clinical and therapeutic advances
Hutson, P. H., Balodis, I. M., & Potenza, M. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.002 · Cited by 71
Pardey, M. C., Kumar, N. N., Goodchild, A. K., & Cornish, J. L. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112465497 · Cited by 61
“NE has also been implicated in impulsivity as the inhibition of NE transporters has been shown to decrease impulsive choice (Robinson et al., 2008), with an increase in impulsive choice following systemic administration of a NE α2 receptor agonist but not an α1 receptor agonist (Van Gaalen et al.”
BackgroundDeepened extinction following compound stimulus presentation: Noradrenergic modulation
Janak, P. H., & Corbit, L. H. (2011) · Learning & Memory · doi:10.1101/lm.1923211 · Cited by 60
“Atomoxetine is a selective NE reuptake inhibitor and has dose-dependent beneficial effects on different forms of impulsivity and behavioral inhibition in rats (Robinson et al. 2008), monkeys (Seu et al.”
BackgroundLin, Z., Canales, J. J., Björgvinsson, Þ., Thomsen, M., Qu, H., Liu, Q., Torres, G. E., & Caine, S. B. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00001-6 · Cited by 64
“Rats trained in a five-choice serial reaction time task increased the percentage of correct responses and decreased the number of premature responses under the influence of reboxetine (89) or atomoxetine (90).”
BackgroundConvergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models
Jupp, B., & Dalley, J. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12787 · Cited by 65
“…↓§ (Blondeau and Dellu-Hagedorn, 2007; Fernando et al., 2012) ↓ (Navarra et al., 2008b; Robinson et al., 2008b; Tsutsui-Kimura et al., 2009) ↓ (Robinson et al., 2008b; Bari et al., 2009) ↓ (Robinson et al., 2008b) = (Baarendse and Vanderschuren, 2012) ↑ (Broos et al., 2012b) ↓…”
BackgroundInfluentialSelf-citationGray, J. C., & MacKillop, J. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01104 · Cited by 53
Cope, Z. A., Halberstadt, A. L., van Enkhuizen, J., Flynn, A. D., Breier, M. R., Swerdlow, N. R., Geyer, M. A., & Young, J. W. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4389-4 · Cited by 58
“Considering the critical role for norepinephrine in tasks requiring inhibition of a learned response (Robinson et al. 2008; Bari and Robbins 2013), it is clear that impulsivity and timing behaviors can be dissociable and, further, may diverge depending on modulation of norepinephrine.”
Warneke, W., Klaus, S., Fink, H., Langley‐Evans, S. C., & Voigt, J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.016 · Cited by 58
Navarra, R. L., Comery, T. A., Graf, R., Rosenzweig-Lipson, S. J., & Day, M. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.016 · Cited by 59
Methylphenidate-induced impulsivity: pharmacological antagonism by β-adrenoreceptor blockade
Milstein, J., Dalley, J., & Robbins, T. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881108098146 · Cited by 55
Self-citationDevelopment and automation of a test of impulse control in zebrafish
Parker, M. O., Ife, D., Ma, J., Pancholi, M. R., Smeraldi, F., Straw, C., & Brennan, C. H. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00065 · Cited by 57
Voon, V. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0036-5 · Cited by 60
Tomlinson, A., Grayson, B., Marsh, S., Harte, M., Barnes, S. A., Marshall, K. M., & Neill, J. C. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.04.008 · Cited by 56
“Doses of both compounds were selected based on previous studies in male rats utilizing the 5-CSRTT (Paterson et al 2011, Robinson et al 2008).”
InfluentialThe influence of emotions on cognitive control: feelings and beliefs—where do they meet?
Harlé, K. M., Shenoy, P., & Paulus, M. P. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00508 · Cited by 62
“Consistent with this hypothesis, both human and animal studies point to a selective facilitating effect of norepinephrine in stopsignal paradigms, improving SSRTs while go reaction times are typically unchanged (Overtoom et al., 2003; Chamberlain et al., 2006; Robinson et al., 2007).”
ResultAmitai, N., & Markou, A. (2011) · Behavioral Neuroscience · doi:10.1037/a0024722 · Cited by 54
“The 5-CSRTT has been used in studies of cognitive disruption with relevance to numerous disorders and conditions, including attention deficit/hyperactivity disorder (ADHD; Barbelivien et al. 2001; Davies et al. 2009; Navarra et al. 2008; Paterson et al. 2011; Puumala et al. 1996; Robinson et al. 2008), aging (Grottick…”
BackgroundMethodUpdate on pathological skin picking
Grant, J. E., & Odlaug, B. L. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0041-x · Cited by 57
Barak, S., & Weiner, I. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.011 · Cited by 52
“Similarly, the norepinephrine reuptake inhibitors desipramine (DMI) and atomoxetine increased omissions and correct response latencies while decreasing premature responses and reward latencies (Paine et al., 2007; Robinson et al., 2008).”
BackgroundHow Is the Norepinephrine System Involved in the Antiepileptic Effects of Vagus Nerve Stimulation?
Berger, A., Vespa, S., Dricot, L., Dumoulin, M., Iachim, E., Doguet, P., Vandewalle, G., & Tahry, R. E. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.790943 · Cited by 59
“Moreover, it was shown that acute systemic administration of atomoxetine, a NE reuptake inhibitor that rapidly increases concentration of NE in the prefrontal cortex, leads to an increased response inhibition in rats and humans (Chamberlain et al., 2006; Robinson et al., 2008).”
BackgroundNoradrenergic modulation of risk/reward decision making
Montes, D. R., Stopper, C. M., & Floresco, S. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3904-3 · Cited by 52
Tsutsui‐Kimura, I., Ohmura, Y., Izumi, T., Yamaguchi, T., Yoshida, T., & Yoshioka, M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305e65 · Cited by 53
Atomoxetine Decreases Vulnerability to Develop Compulsivity in High Impulsive Rats
Ansquer, S., Belin‐Rauscent, A., Dugast, E., Duran, T., Bénatru, I., Mar, A. C., Houéto, J., & Belin, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.031 · Cited by 49
Self-citationVriend, C. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2771-0 · Cited by 52
“Overall, it can be stated that increases in noradrenergic signaling improve impulse control (Baarendse et al. 2013; Chamberlain et al. 2007; Robinson et al. 2008) but the mechanism is still unknown and is partly dependent on the subtype of impulsive behavior (see Bari and Robbins 2013 for a review).”
Lithium, but not valproic acid or carbamazepine, suppresses impulsive-like action in rats
Ohmura, Y., Tsutsui‐Kimura, I., Kumamoto, H., Minami, M., Izumi, T., Yamaguchi, T., Yoshida, T., & Yoshioka, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2496-9 · Cited by 52
“, noradrenalin reuptake inhibitors and atypical antipsychotic drugs) stimulate dopamine release in the medial prefrontal cortex in rats (Amitai et al. 2007; Bymaster et al. 2002; Cartmell et al. 2000; Greco et al. 2005; Kitaichi et al. 2008; Li et al. 2009; Pattij et al. 2007; Robinson et al. 2008; Schmidt and Fadayel…”
BackgroundResultWooters, T. E., & Bardo, M. T. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.040 · Cited by 46
“…studies have also shown that amphetamine (van Gaalen et al., 2006; Wade et al., 2000; Winstanley et al., 2005), atomoxetine (Navarra et al., 2008; Robinson et al., 2008), methamphetamine (Richards et al., 1999) and methylphenidate (Adriani et al., 2007; Pitts and McKinney, 2005; van Gaalen et…”
BackgroundEffects of α-2A adrenergic receptor agonist on time and risk preference in primates
Kim, S., Bobeica, I., Gamo, N. J., Arnsten, A. F. T., & Lee, D. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2520-0 · Cited by 47
“Similarly, the selective norepinephrine uptake inhibitor, atomoxetine, which increases both dopamine and norepinephrine in rat prefrontal cortex (Bymaster et al. 2002), reduces the rat's preference for immediate reward (Robinson et al. 2008).”
BackgroundPotter, A. S., Bucci, D. J., & Newhouse, P. A. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2476-0 · Cited by 46
“2009; 2006) and rodents (Robinson et al. 2008) that are not rate-dependent.”
Noradrenergic α2A-receptor stimulation in the ventral hippocampus reduces impulsive decision-making
Abela, A. R., & Chudasama, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3262-y · Cited by 50
“2006) likewise improve tolerance for delayed rewards (Robinson et al. 2008; Shiels et al. 2009).”
BackgroundPattij, T., Schetters, D., Schoffelmeer, A. N. M., & van Gaalen, M. M. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2405-2 · Cited by 46
“2007), recent studies have demonstrated that atomoxetine also improves inhibitory response control in several translational rodent models (Bari et al. 2009; Blondeau and Dellu-Hagedorn 2007; Robinson et al. 2008).”
Impulsive Behavior and Nicotinic Acetylcholine Receptors
Ohmura, Y., Tsutsui‐Kimura, I., & Yoshioka, M. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r06cr · Cited by 50
The effects of early life stress on impulsivity
Sanchez, E. O., & Bangasser, D. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104638 · Cited by 48
Voon, V., & Dalley, J. W. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5013 · Cited by 53
Self-citationAnimal models to guide clinical drug development in ADHD: lost in translation?
Wickens, J. R., Hyland, B. I., & Tripp, G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01412.x · Cited by 52
“The SSRT is also improved by stimulants (Tannock et al., 1989; Bedard et al., 2003), but the effects may be selective for children with slow SSRTs (Boonstra et al., 2005).”
BackgroundInfluentialYates, J. R., Perry, J. L., Meyer, A. C., Gipson, C. D., Charnigo, R. J., & Bardo, M. T. (2014) · Brain Research · doi:10.1016/j.brainres.2014.06.004 · Cited by 50
“…sensitivity to delay in the adjusting delay procedure (Perry et al., 2008b) and in the progressive delay procedure (Pitts and McKinney, 2005; Robinson et al., 2008; van Gaalen et al., 2006; Wade et al., 2000; Winstanley et al., 2003; Winstanley et al., 2005; but see Broos et al., 2012;…”
The effect of vagus nerve stimulation on response inhibition
Schevernels, H., van Bochove, M. E., Taeye, L. D., Bombeke, K., Vonck, K. E. J., Roost, D. V., Herdt, V. D., Santens, P., Raedt, R., & Boehler, C. N. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.09.014 · Cited by 50
Humby, T., Eddy, J. B., Good, M. A., Reichelt, A. C., & Wilkinson, L. S. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.112 · Cited by 44
“…inhibitory processes mediating stopping in the SSRTT (this work), premature responding in the five-choice serial reaction time task (Fletcher et al , 2007; Robinson et al , 2008a; Winstanley et al , 2004) or choosing in the delayed reinforcement task (Paterson et al , 2012; Robinson et al , 2008a).”
Benn, A., & Robinson, E. S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115374 · Cited by 44
“The timings for the VITI were based on previous studies where this approach has been used as an acute manipulation in the standard 5CSRTT [31, 32].”
Self-citationParker, M. O., Brock, A. J., Sudwarts, A., & Brennan, C. H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3439-z · Cited by 44
“Our data show that in fish, selective increases in noradrenergic activity increase the ability to withhold a response on this task representing similar patterns to those observed in rats (Robinson et al. 2008) and human patients with ADHD (Chamberlain et al. 2007).”
InfluentialCortical dopamine release during a behavioral response inhibition task
Albrecht, D., Kareken, D. A., Christian, B. T., Džemidžić, M., & Yoder, K. K. (2014) · Synapse · doi:10.1002/syn.21736 · Cited by 53
“Several studies reported that atomoxetine (ATM), a selective norepinephrine (NE) reuptake inhibitor, improves SSRT in both humans (Chamberlain et al., 2006, 2009) and small animals (Bari et al., 2009, 2011; Robinson et al., 2008).”
BackgroundJentsch, J. D., Aarde, S. M., & Seu, E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1181-0 · Cited by 43
“Using fixed intertrial interval schedules, Robinson et al. (2007) and Blondeau and Dellu-Hagedorn (2007) observed no effect of systemically administered atomoxetine on accuracy in the five-choice task.”
BackgroundResultInfluentialConsideration of species differences in developing novel molecules as cognition enhancers
Young, J. W., Jentsch, J. D., Bussey, T. J., Wallace, T. L., & Hutcheson, D. M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.002 · Cited by 42
“Because NET inhibition might act as a global inhibitory signal in tasks requiring reduced responding (Robinson et al., 2008), the selectivity of amphetamine for NET over DAT in mice could influence its lack of effects on premature responding.”
Bradshaw, S. E., Agster, K. L., Waterhouse, B. D., & McGaughy, J. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.001 · Cited by 44
Wolff, N., Mückschel, M., Ziemssen, T., & Beste, C. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1531-y · Cited by 43
“Conflict monitoring and inhibition processes have been shown to be modulated by the NE system (Robinson et al. 2008; Chamberlain et al. 2009; Steenbergen et al. 2015b; Mückschel et al. 2016; Beste et al. 2016; Chmielewski et al. 2017).”
BackgroundSmethells, J. R., Swalve, N. L., Eberly, L. E., & Carroll, M. E. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4345-3 · Cited by 41
“The ATO dose was selected based on previous research showing it reduced cocaine seeking (Swavle et al. 2016; Zlebnik and Carroll 2014) and impulsive choice at doses of 1–2 mg/kg (e.g., Bizot et al. 2011; Robinson et al. 2008).”
BackgroundMethodResultInfluentialRodent Test of Attention and Impulsivity: The 5‐Choice Serial Reaction Time Task
Higgins, G. A., & Silenieks, L. B. (2017) · Current Protocols in Pharmacology · doi:10.1002/cpph.27 · Cited by 43
Wilson, C. A., Schade, R., & Terry, A. V. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.040 · Cited by 40
“Doses were chosen based on efficacy in previously published 5C-SRTT studies (Navarra et al., 2008, Robinson et al., 2008).”
MethodBizot, J., David, S., & Trovero, F. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.11.058 · Cited by 43
London, E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01120 · Cited by 41
“This circuitry is responsible for the initiation or the stopping of movements as well as thought and cognition, attention impulses, emotions and complex actions (154, 155) and there is evidence that these circuits are regulated by NE as well as dopamine (156, 157).”
BackgroundAndersen, S. L., & Navalta, C. P. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02376.x · Cited by 38
“In the single study in juvenile animals, 1 mg/kg atomoxetine reduced hyperactivity (Robinson et al., 2008).”
Modeling Deficits in Attention, Inhibition, and Flexibility in HAND
Moran, L. M., Booze, R. M., & Mactutus, C. F. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9539-z · Cited by 40
“Increased NE activity in the OFC has been associated with improved response inhibition (Bari et al. 2009; Robinson et al. 2008) and reversal learning (Seu and Jentsch 2009).”
Prenatal Nicotine Exposure Impairs Executive Control Signals in Medial Prefrontal Cortex
Bryden, D. W., Burton, A. C., Barnett, B. R., Cohen, V. J., Hearn, T., Jones, E. A. A., Kariyil, R., Kunin, A., Kwak, S. I., Lee, J., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.197 · Cited by 40
Robbins, T. W., & Crockett, M. J. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70093-x · Cited by 42
Self-citationPersonality driven alcohol and drug abuse: New mechanisms revealed
Nalberczak‐Skóra, M., Pattij, T., Beroun, A., Kogias, G., Mielenz, D., Vries, T. J. D., Radwańska, K., & Müller, C. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.023 · Cited by 43
Bari, A., & Robbins, T. W. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_102 · Cited by 39
“Using the SST, Eagle et al. (2008b) showed that lesions of the OFC impair stopping performance in the rat, while Bari et al. (unpublished) found that reversible inactivation of dorso-medial PFC by local infusion of muscimol selectively slowed SSRT.”
BackgroundMethodResultInfluentialSelf-citationDisordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington’s Disease
Morris, L., O'Callaghan, C., & Le Heron, C. (2022) · Movement Disorders · doi:10.1002/mds.29013 · Cited by 36
Fitzgerald, P. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1856-1 · Cited by 38
Reinforcement, Dopamine and Rodent Models in Drug Development for ADHD
Tripp, G., & Wickens, J. R. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0132-y · Cited by 42
“Psychostimulants and atomoxetine decrease impulsivity on the SSRT [143], suggesting that this task may be useful in animal studies of potential therapeutic agents.”
BackgroundAtomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor ‘knockout’ mice
Pillidge, K., Porter, A. J., Vasili, T., Heal, D. J., & Stanford, S. C. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.10.008 · Cited by 36
“In Long Evans and Lister-hooded rats, this drug reduces premature responses (impulsivity) (Fernando et al., 2012; Paterson et al., 2011; Robinson, 2012; Robinson et al., 2008) but has negligible effects on omissions (inattention).”
InfluentialStolerman, I. P., & Price, L. H. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_200815 · Cited by 36
Rodent Model of Attention: The 5‐Choice Serial Reaction Time Task
Higgins, G. A., & Breysse, N. (2008) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0549s41 · Cited by 38
Adolescent morphine exposure induces immediate and long-term increases in impulsive behavior
Moazen, P., Azizi, H., Salmanzadeh, H., & Semnanian, S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5051-0 · Cited by 38
Navarro, S., Gutiérrez-Ferre, V. E., Flores, P., & Moreno, M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3699-7 · Cited by 36
Bayless, D. W., Darling, J. S., & Daniel, J. M. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.10.003 · Cited by 34
Toschi, C., Hervig, M. E.-S., Moazen, P., Parker, M. G., Dalley, J. W., Gether, U., & Robbins, T. W. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05883-y · Cited by 34
Self-citationFunctional Coupling of the Locus Coeruleus Is Linked to Successful Cognitive Control
Grueschow, M., Kleim, B., & Ruff, C. C. (2022) · Brain Sciences · doi:10.3390/brainsci12030305 · Cited by 37
Dissecting Impulsivity: Brain Mechanisms and Neuropsychiatric Implications
Robbins, T. W., & Dalley, J. W. (2017) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-3-319-51721-6_7 · Cited by 37
Self-citationFitzpatrick, C. M., Runegaard, A. H., Christiansen, S. H., Hansen, N. W., Jørgensen, S. H., McGirr, J. C., Ajenjo, A. D. D., Sørensen, A. T., Perrier, J., Petersen, A., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.004 · Cited by 34
“This is supported by the belief that the norepinephrine transporter reuptake inhibitor atomoxetine exerts its clinically-relevant impulsive-reducing effects through improved top-down cognitive control (Robinson et al., 2008; Bush et al., 2010; Clemow and Bushe, 2015), although no previous lesion studies have implicate…”
Steep Discounting of Future Rewards as an Impulsivity Phenotype: A Concise Review
Levitt, E. E., Sanchez‐Roige, S., Palmer, A. A., & MacKillop, J. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_128 · Cited by 36
Noradrenergic contributions to cue-driven risk-taking and impulsivity
Chernoff, C. S., Hynes, T. J., & Winstanley, C. A. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05806-x · Cited by 34
Seu, E., & David Jentsch, J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.007 · Cited by 31
“, 2000b) and otherwise normal animal models (Berridge et al., 2006; Eagle et al., 2007; Navarra et al., 2008; Robinson et al., 2007; Seu et al., 2009), indicating that their cognitive-enhancing actions may result from acute dosing, assuming a clinically meaningful dose is used.”
BackgroundInfluentialMar, A. C., Nilsson, S. R. O., Gamallo‐Lana, B., Lei, M., Dourado, T., Alsiö, J., Saksida, L. M., Bussey, T. J., & Robbins, T. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4679-5 · Cited by 34
“…been widely observed in both rodents and humans tested on a variety of cognitive paradigms (Blondeau and Dellu-Hagedorn 2007; Navarra et al. 2008; Robinson et al. 2008; Paterson et al. 2011; Fernando et al. 2011; Baarendse and Vanderschuren 2011; Robinson 2012; Chamberlain et al. 2006, 2007;…”
BackgroundSelf-citationPromising Medications for Cocaine Dependence Treatment
Somaini, L., Donnini, C., Raggi, M. A., Amore, M., Ciccocioppo, R., Saracino, M. A., Kallupi, M., Malagoli, M., Gerra, M. L., & Gerra, G. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488911795933893 · Cited by 32
“It is known to improve response inhibition in humans and to decrease impulsivity in animals [119].”
BackgroundCaballero-Puntiverio, M., Fitzpatrick, C. M., Woldbye, D. P. D., & Andreasen, J. T. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116684339 · Cited by 30
“, 2014), and it has been postulated that selective inhibition of the noradrenaline transporter in the prefrontal cortex (PFC) may reduce impulsivity (Robinson et al., 2008).”
BackgroundInfluentialHumby, T., & Wilkinson, L. S. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.06.006 · Cited by 32
“Chamberlain SR, Hampshire A, Müller U, Rubia K, Del Campo N, Craig K, Regenthal R, Suckling J, Roiser JP, Grant JE, Bullmore ET, Robbins TW, Sahakian BJ: Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.”
Pharmacology of Economic and Social Decision Making
Crockett, M. J., & Fehr, E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416008-8.00014-0 · Cited by 34
Zlebnik, N. E., & Carroll, M. E. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3744-6 · Cited by 28
“2008), and delay-discounting (Bizot et al. 2011; Robinson et al. 2008) tasks (but see Baarendse and Vanderschuren 2012; Broos et al.”
InfluentialAnker, J. J., Zlebnik, N. E., Gliddon, L. A., & Carroll, M. E. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305ea2 · Cited by 32
“, 2007) and preclinical (Feola et al., 2000; Eagle and Robbins, 2003; Eagle et al., 2007; Robinson et al., 2008) research indicate that stimulants decrease impulsivity when baselines are high, and they increase or have no effect on impulsivity measures when baselines are normal or low.”
BackgroundSchippers, M. C., Schetters, D., Vries, T. J. D., & Pattij, T. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4337-3 · Cited by 28
“Besides the modulation of stress, noradrenaline is also implicated in impulsive behavior (Baarendse and Vanderschuren 2012; Bari et al. 2009; Pattij and Vanderschuren 2008; Pattij et al. 2012; Robinson et al. 2007; Winstanley 2011).”
BackgroundNandam, L. S., Hester, R., & Bellgrove, M. A. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.01.023 · Cited by 29
“…methylphenidate and atomoxetine have also been shown to augment response inhibition in wild-type animals (Eagle, Tufft, Goodchild, & Robbins, 2007; Robinson et al., 2008) and healthy adults (Chamberlain, Muller, Cleary, Robbins, & Sahakian, 2007; Nandam et al., 2011), suggesting that these agents…”
The putative lithium-mimetic ebselen reduces impulsivity in rodent models
Barkus, C., Ferland, J. N., Adams, W. K., Churchill, G. C., Cowen, P. J., Bannerman, D. M., Rogers, R. D., Winstanley, C. A., & Sharp, T. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118784876 · Cited by 27
Liu, Y., Huang, T.-S., Tung, C., & Lin, C.-C. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.007 · Cited by 28
“While atomoxetine has no influence on attentional accuracy in the 5-CSRTT, it decreases premature responding in baseline conditions and situations with altered cognitive demand (Fernando et al., 2012; Robinson, 2012; Robinson et al., 2008).”
Davies, W., Humby, T., Trent, S., Eddy, J. B., Ojarikre, O. A., & Wilkinson, L. S. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.115 · Cited by 32
“…HCl (n=12, at doses of 0, 0.6, 1, 3 and 5mg/kg, Sigma, U.K.), at doses shown previously to be effective at modifying rodent SSRTT behavior (Humby et al., 2013; Robinson et al., 2008a; Eagle et al., 2007), were made up in physiological saline and administered 30mins prior to testing (i.p.).”
InfluentialEffects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat
Turner, M., Wilding, E., Cassidy, E., & Dommett, E. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.025 · Cited by 27
Tan, D., Soh, L. J. T., Lim, L. W., Daniel, T. C. W., Zhang, X., & Vyas, A. (2015) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2015.0042 · Cited by 31
“For example, administration of atomoxetine, resulting in 263 increased dopamine in the prefrontal cortex but not the nucleus accumbens, decreases 264 impulsivity in delay discounting task and 5-choice serial reaction time task [39].”
BackgroundKoffarnus, M. N., & Katz, J. L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2027-0 · Cited by 27
“Atomoxetine has been shown to both increase the percentage of correct responses (Navarra et al. 2007), or have no effect (Robinson et al. 2008).”
InfluentialHumpston, C. S., Wood, C. M., & Robinson, E. S. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112466182 · Cited by 29
“A role for the NAT in these effects is in keeping with the efficacy of noradrenergic agents in treating impulse control disorders (Navarra et al., 2008) and their effects in animal studies (for example see Blondeau and Dellu-Hagedorn, 2006; Floresco and Jentsch 2011, Robinson et al., 2008a).”
BackgroundResultInfluentialSelf-citationHiggins, G. A., Silenieks, L. B., MacMillan, C., Thevarkunnel, S., Parachikova, A. I., Mombereau, C., Lindgren, H. S., & Bastlund, J. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00427 · Cited by 28
Behavioral Animal Models to Assess Pro-cognitive Treatments for Schizophrenia
Young, J. W., Amitai, N., & Geyer, M. A. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_3 · Cited by 29
Models of attention-deficit hyperactivity disorder
Killeen, P. R. (2019) · Behavioural Processes · doi:10.1016/j.beproc.2019.01.001 · Cited by 29
Hammond, C. J., Potenza, M. N., & Mayes, L. C. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195389715.013.0082 · Cited by 33
Differential long-term medication impact on executive function and delay aversion in ADHD
Morell, B. R., & Expósito, S. H. (2017) · Applied Neuropsychology Child · doi:10.1080/21622965.2017.1407653 · Cited by 26
“nificantly decreases impulsivity by increasing preference for the large-value reward across increasing delay (Robinson et al., 2008).”
BackgroundWaiting Impulsivity: The Influence of Acute Methylphenidate and Feedback
Voon, V., Chang-Webb, Y. C., Morris, L. S., Cooper, E., Sethi, A., Baek, K., Grant, J. E., Robbins, T. W., & Harrison, N. A. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv074 · Cited by 27
“Atomoxetine consistently decreased premature responding and, less consistently, improved attention in rodents on both the 5-CSRT (Robinson et al., 2008; Baarendse and Vanderschuren, 2012; Fernando et al., 2012; Paterson et al., 2012) and in a rodent gambling task (Baarendse et al.”
BackgroundSelf-citationHoffmeister, J. D., Kelm‐Nelson, C. A., & Ciucci, M. R. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113642 · Cited by 27
Metadata
- Authors
- Robinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Eagle, Dawn M
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2007-07-18
- Volume
- 33
- Issue
- 5
- Pages
- 1028-1037
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1992488100
- Cited by
- 359
- References
- 66
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 16 · 2023: 11 · 2022: 15 · 2021: 17 · 2020: 13 · 2019: 10 · 2018: 18 · 2017: 21 · 2016: 21 · 2015: 20 · 2014: 37 · 2013: 23 · 2012: 25
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- Wellcome Trust
- British Pharmacological Society
- Research Councils UK
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- atomoxetine, impulsivity, attention deficit hyperactivity disorder, norepinephrine reuptake inhibition, stop-signal reaction time, delay discounting, 5-choice serial reaction time task, visual attention, stimulants, amphetamine, methylphenidate, rats
- MeSH terms
- Atomoxetine Hydrochloride, Analysis of Variance, Animals, Behavior, Animal, Choice Behavior, Dose-Response Relationship, Drug, Impulsive Behavior, Inhibition, Psychological, Male, Propylamines, Reaction Time, Reinforcement, Psychology, Reinforcement Schedule, Task Performance and Analysis, Adrenergic Uptake Inhibitors, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.